| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Williamson Robert F III serves as a Director at CATX. Across recent SEC filings that breaks down to 25 buys and 0 sells. Those positions are worth an estimated $21K at current prices.
Historically, Williamson Robert F III's trades have earned a middling insider score of 63/100 across 14 rated trades. Over a 12-month horizon, 23.1% of those trades were profitable, with an average 12-month return of -16.2%.
The biggest single holding is CATX (~$21K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 503,556 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | CATX Perspective Therapeutics, Inc. | Director | Buy | 9,498 | $2.10 | $19,945.80 | +2,595% | +123.6% | - | |
| Mar 31, 2025 | CATX Perspective Therapeutics, Inc. | Director | Buy | 60,337 | $2.19 | $132,151.09 | +124.0% | +61.5% | +95.8% | |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 6,266 | $3.64 | $22,813.51 | +1.5% | -26.0% | -40.7% | |
| May 31, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 55,000 | $1.38 | $75,900.00 | +14.9% | +12.9% | -81.4% | |
| May 29, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 30,031 | $1.33 | $40,014.04 | +8.9% | +13.3% | -80.0% | |
| Jan 30, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 127,206 | $0.71 | $90,710.05 | +60.1% | +118.4% | -51.9% | |
| Jan 29, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 135,879 | $0.58 | $78,473.91 | +179.6% | +144.0% | -45.5% | |
| Jan 25, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 51,996 | $0.49 | $25,478.04 | +219.6% | +228.8% | -22.0% | |
| Dec 21, 2023 | CATX Perspective Therapeutics, Inc. | Director | Buy | 3,663 | $0.33 | $1,202.56 | New | +258.0% | -15.0% | |
| Dec 19, 2023 | CATX Perspective Therapeutics, Inc. | Director | Buy | 23,680 | $0.29 | $6,977.60 | New | +185.8% | -12.1% |